Scinai Immunotherapeutics (SCNI) Total Current Liabilities (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Total Current Liabilities for 2 consecutive years, with $1.6 million as the latest value for Q4 2025.
- Quarterly Total Current Liabilities fell 12.24% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, down 12.24% year-over-year, with the annual reading at $1.6 million for FY2025, 12.24% down from the prior year.
- Total Current Liabilities hit $1.6 million in Q4 2025 for Scinai Immunotherapeutics, down from $1.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.8 million in Q4 2024 to a low of $1.6 million in Q4 2025.